Glycaemic control and cardiovascular outcome trials in type 2 diabetes

Clifford J. Bailey, Caroline Day, Ian W. Campbell, Christoph Schindler

Research output: Contribution to journalArticle

Abstract

Large prospective trials designed to assess the relationship between metabolic control and CV outcomes in type 2 diabetes have entered a new phase of scrutiny due to strict requirements imposed by the FDA to assess new anti-diabetic agents. So what have we learned from recently completed trials and what do we expect to learn from on-going trials?
Original languageEnglish
Pages (from-to)161-164
Number of pages4
JournalBritish Journal of Diabetes and Vascular Disease
Volume12
Issue number4
DOIs
Publication statusPublished - Jul 2012

Fingerprint Dive into the research topics of 'Glycaemic control and cardiovascular outcome trials in type 2 diabetes'. Together they form a unique fingerprint.

  • Cite this